IPSEN PHARMACEUTICALS, INC.
IPSEN PHARMACEUTICALS, INC.
Industry:
Biotechnology Health Care
Founded:
2005-01-01
Address:
Morristown, New Jersey, United States
Country:
United States
Status:
Active
Contact:
973-867-5555
Similar Organizations
Oclassen Pharmaceuticals
Oclassen Pharmaceuticals, Inc. was acquired by Watson Pharmaceuticals Inc.
More informations about "Ipsen Pharmaceuticals, Inc."
About Ipsen | Pioneering Biopharmaceutical Company - Global
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society. ... We do this by striving to …See details»
Who We Are - ipsen.com
We are a global, mid-size pharmaceutical company focusing on areas of high unmet medical need. Focus. Together. For patients and society. ABOUT IPSEN ... Functioning independently of Ipsen, Fondation Ipsen is dedicated to …See details»
Ipsen – improving patient health outcomes - Ipsen …
Ipsen is dedicated to safeguarding and preserving our planet. The Generation Ipsen ESG sustainability strategy lays out ambitious goals for the company in each of our four pillars: Environment, Patients, People and Governance. Learn …See details»
Ipsen - Wikipedia
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases …See details»
Ipsen Pharmaceuticals, Inc. - Crunchbase Company Profile
Ipsen Pharmaceuticals, Inc. delivered strong financial results in the first half of 2024, leading to an upgrade in its full-year guidance. The company also secured ex-US rights to a pediatric cancer …See details»
Ipsen - Crunchbase Company Profile & Funding
Ipsen is a global specialty-driven biopharmaceutical company focused on innovation and specialty care. New. ... Pharmaceutical . Product Research . Headquarters Regions European Union …See details»
Ipsen: a dynamic, fast-growing specialty care …
Ipsen is the first company to test recombinant toxins in preclinical and phase 1 clinical studies 4; the strong internal expertise of its R&D teams has played a critical role in the establishment ...See details»
Ipsen | Company Overview & News - Forbes
Ipsen SA manufactures pharmaceutical products for oncology, neuroscience and rare diseases. It operates through following segments: Specialty Care and Consumer Healthcare. The …See details»
Ipsen Pharmaceuticals, Inc. – Biopharma
Milford, MA; U.S. subsidiary of Ipsen S.A.; formerly Speywood Pharmaceuticals, Inc., founded in 1986 in Los Angeles, CA, to market Speywood Group, Porton ...See details»
Ipsen Biopharmaceuticals - MassBio
Ipsen is a global specialty-driven pharmaceutical group with total sales exceeding €1.4 billion in 2015. Ipsen sells more than 20 drugs in more than 115 countries, with a direct commercial …See details»
Ipsen Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 Ipsen is a global specialty-driven biotechnological group with total sales exceeding €1.2 billion in 2014 in more than 115 countries, with a direct commercial presence in 30 …See details»
IPSEN BIOPHARMACEUTICALS CANADA INC - Drug and Health …
IPSEN BIOPHARMACEUTICALS CANADA INC. Share: Company address. 5050 Satellite Drive Mississauga, Ontario, L4W 0G1, Canada Product name DIN Active ingredient(s) & strength; …See details»
Member profile: Ipsen Biopharm Ltd | BIA - bioindustry.org
Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of this transformation. Ipsen also has a well-established Consumer Healthcare business. With total …See details»
Ipsen Biopharmaceuticals, Inc. - VentureRadar
Ipsen Bioscience, Inc., the Ipsen US research and development center focused on peptide research in oncology and endocrinology, is located in Cambridge, Massachusetts. At Ipsen Bioscience, we focus on creating a highly cooperative and passionate R&D organization through partnerships, innovation, and continuous learning to effectively deliver new treatments for …See details»
Ipsen Pharma Company Profile | Management and Employees List
Ipsen Pharma Profile and History Founded in 1929 and headquartered in Boulogne, France, Ipsen Pharma is a global biopharmaceutical group focused on specialty care. The Group …See details»
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin ...
DEER PARK, Ill., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on …See details»
Ipsen - Funding, Financials, Valuation & Investors - Crunchbase
Ipsen 's most notable exits include Xilio Therapeutics, Pyxis Oncology, and Rhythm Pharmaceuticals. Ipsen has acquired 11 organizations. Their most recent acquisition was Albireo Pharma on Jan 9, 2023. They acquired Albireo Pharma for $952M.See details»
Ipsen Pharmaceuticals, Inc. - Harrisburg - Company Information
You can find this business by geo coordinates: 40° 15' 42" N , 76° 53' 10.1" W. Ipsen Pharmaceuticals, Inc. was incorporated on Wednesday 20th August 2008, so this company age is sixteen years, seven months and twenty-three days. Current company status of …See details»
Ipsen (IPNPA): history, ownership, mission, how it works & makes …
[relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of Ipsen S.A. Founded in 1929, Ipsen S.A. began as a small pharmaceutical company in France. …See details»
Correction: Ipsen enregistre une solide croissance de ses
17 hours ago Ipsen ne peut être certain que ses partenaires tiendront leurs engagements. À ce titre, le Groupe pourrait ne pas être en mesure de bénéficier de ces accords. Une défaillance …See details»